Finance

Lists
Why is SAILIFE down 2.28%?
Dive Deeper
SAILIFE:NSE
Sai Life Sciences Ltd
₹1,506.00
-2.28%
(-35.20) 1D
Oct 5, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for SAILIFE...
Open
₹1,549.50
High
₹1,557.90
Low
₹1,501.00
Mkt. cap
314.75B
Avg. vol.
732.60K
Volume
325.81K
P/E ratio
88.61
52-wk high
₹1,697.00
52-wk low
₹783.85
EPS
₹17.00
No. of employees
5K
Open
₹1,549.50
High
₹1,557.90
Low
₹1,501.00
Mkt. cap
314.75B
Avg. vol.
732.60K
Volume
325.81K
P/E ratio
88.61
52-wk high
₹1,697.00
52-wk low
₹783.85
EPS
₹17.00
No. of employees
5K
News stories
From web sources and news partners
Profile
Sai Life Sciences Limited is an Indian contract research, development, and manufacturing organisation, headquartered in Hyderabad, Telangana. The company provides drug discovery, development, contract manufacturing services for small-molecule new chemical entities to pharmaceutical and biotechnology companies. The company was established in Hyderabad in January 1999 as Sai Dru Syn Laboratories Limited. It was later renamed Sai Life Sciences Limited. It operates R&D and manufacturing facilities in India, the UK, and the USA. Wikipedia
About Sai Life Sciences Ltd
CEO-
Employees5.22K
Founded1999
Headquarters-
SectorHealth care
Websitesailife.com
Last report
Aug 7, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹3.42 / ₹3.60
-5.00%miss
Revenue / Est. (INR)
5.54B / 5.65B
-1.84%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.37B
5.56B
6.02B
5.54B
Cost of goods sold
1.40B
1.28B
2.27B
1.45B
Cost of revenue
1.40B
1.28B
2.27B
1.45B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.63B
1.73B
1.96B
1.80B
Operating expense
2.91B
2.85B
2.43B
3.07B
Total operating expenses
4.31B
4.13B
4.70B
4.52B
Operating income
1.06B
1.44B
1.32B
1.02B
Other non operating income
153.25M
83.80M
-333.80M
35.43M
EBT including unusual items
1.12B
1.34B
1.39B
979.74M
EBT excluding unusual items
1.12B
1.42B
1.39B
979.74M
Income tax expense
282.07M
337.91M
349.91M
246.89M
Effective tax rate
25.17%
25.19%
25.13%
25.20%
Other operating expenses
887.29M
676.72M
14.63M
814.72M
Net income
838.44M
1.00B
1.04B
732.85M
Net profit margin
15.60%
18.04%
17.31%
13.22%
Earnings per share
3.93
5.00
4.86
3.42
Interest and investment income
-
-
186.18M
-
Interest expense
-93.51M
-96.99M
-78.25M
-76.36M
Net interest expenses
-93.51M
-96.99M
107.93M
-76.36M
Depreciation and amortization charges
397.48M
440.75M
453.08M
459.37M
EBITDA
1.45B
1.66B
1.60B
1.44B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps